Dealing with unanticipated mortality in a large randomized clinical trial of topical tretinoin

Arch Dermatol. 2009 Jan;145(1):76. doi: 10.1001/archdermatol.2008.520.
No abstract available

Publication types

  • Comment
  • Editorial
  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Administration, Topical
  • Antineoplastic Agents / adverse effects*
  • Cause of Death*
  • Humans
  • Randomized Controlled Trials as Topic
  • Skin Neoplasms / prevention & control
  • Tretinoin / adverse effects*

Substances

  • Antineoplastic Agents
  • Tretinoin